← Back to Search

Cerena™ for Cancer (RESTORE Trial)

N/A
Waitlist Available
Led By Dianne M Shumay
Research Sponsored by Blue Note Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are experiencing at least moderate anxiety
Stage I-III cancer diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

RESTORE Trial Summary

This trial will compare how well two digital software devices help improve anxiety and other indicators of psychological and physical health in patients with cancer. The study will be completely virtual, so participants can take part from home.

RESTORE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

RESTORE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Symptoms of anxiety
Secondary outcome measures
Acceptability of each digital product
Benefit Finding
Cancer-related symptoms of anxiety (thought intrusions)
+12 more
Other outcome measures
Healthcare utilization

RESTORE Trial Design

2Treatment groups
Active Control
Group I: Cerena™Active Control1 Intervention
Cerena™ is a completely digital therapeutic intervention.
Group II: Attune™Active Control1 Intervention
Attune™ is a completely digital therapeutic intervention.

Find a Location

Who is running the clinical trial?

Blue Note TherapeuticsLead Sponsor
6 Previous Clinical Trials
429 Total Patients Enrolled
Curebase Inc.Industry Sponsor
6 Previous Clinical Trials
3,237 Total Patients Enrolled
CurebaseUNKNOWN
2 Previous Clinical Trials
1,415 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available for participants in this investigation?

"The clinical trail noted on clinicaltrials.gov is no longer recruiting patients, with the first announcement posted on March 10th 2022 and most recent edits occurring on October 18th of the same year. That said, there are 486 other studies actively enrolling participants at this time."

Answered by AI
~117 spots leftby Mar 2025